Free Trial

Carl Zeiss Meditec (ETR:AFX) Stock Price Down 5.7% - Time to Sell?

Carl Zeiss Meditec logo with Medical background

Carl Zeiss Meditec AG (ETR:AFX - Get Free Report) traded down 5.7% during trading on Friday . The stock traded as low as €50.85 ($53.53) and last traded at €50.95 ($53.63). 489,838 shares changed hands during mid-day trading, an increase of 419% from the average session volume of 94,405 shares. The stock had previously closed at €54.05 ($56.89).

Carl Zeiss Meditec Stock Performance

The company has a debt-to-equity ratio of 6.74, a quick ratio of 2.47 and a current ratio of 3.51. The business's fifty day moving average price is €60.07 and its 200-day moving average price is €64.64. The stock has a market cap of $4.56 billion, a PE ratio of 22.35, a P/E/G ratio of 2.83 and a beta of 0.98.

Carl Zeiss Meditec Company Profile

(Get Free Report)

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Carl Zeiss Meditec right now?

Before you consider Carl Zeiss Meditec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carl Zeiss Meditec wasn't on the list.

While Carl Zeiss Meditec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines